Security Defense Systems v. Athena Health — Case Dismissed in 99 Days
Security Defense Systems, LLC brought a patent infringement action against Athena Health, Inc. in the Western District of Texas, asserting US8155887B2 covering computer visualized drug interaction information retrieval. The case closed in just 99 days — well before any answer or summary judgment motion was filed.
A swift pre-answer exit: drug interaction patent dropped in 99 days
On April 26, 2023, Security Defense Systems, LLC filed a patent infringement complaint against Athena Health, Inc. in the Western District of Texas before Judge Robert Pitman. The sole patent in suit, US8155887B2 (application no. US12/191759), covers computer visualized drug interaction information retrieval technology. Athena Health is a health IT company, and the asserted technology sits squarely within the clinical decision-support and electronic health records domain.
On August 2, 2023, the plaintiff filed a notice of dismissal of all claims with prejudice under Federal Rule of Civil Procedure 41(a)(1)(A)(i). Because the defendant had not yet served an answer or a motion for summary judgment, the notice was self-effectuating and required no court order. The court's August 2 order acknowledged this procedural posture and directed the clerk to close the case. The recorded Basis of Termination is 'Case Dismissed'; the docket order states that the plaintiff dismissed all claims with prejudice pursuant to Rule 41(a)(1)(A)(i).
The case resolved in 99 days — unusually quickly — without any substantive briefing on the merits. Because no answer, discovery, or dispositive motions were filed, no invalidity defences or claim construction positions appear in the public record. The specific reasons driving the dismissal are not disclosed in the available record.
See Complete Case & Patent Analysis →Filing to Case Dismissed in 99 days
Days from filing to closure — resolved before defendant filed any responsive pleading
US8155887B2 — computer visualized drug interaction information retrieval
Any organisation developing or commercialising EHR systems, pharmacy integration tools, clinical decision-support modules, or health apps that visualise drug interaction data should treat US8155887B2 as a live risk. The patent has never been subject to claim construction, and no invalidity record exists from this litigation. Product teams shipping drug interaction retrieval or display features should assess their freedom to operate before those features reach market.
Official order — verbatim text
The court's August 2, 2023 order confirms the case closed on a procedural basis under Rule 41(a)(1)(A)(i), with the plaintiff's notice of dismissal being self-effectuating. No merits determination was made, and no claim construction or invalidity findings appear in the record. The recorded Basis of Termination is 'Case Dismissed'; the docket order states the dismissal was with prejudice. The specific terms, if any, underlying the plaintiff's decision to dismiss are not disclosed in the available record.
Case dismissed: what the voluntary exit means for both parties
Rule 41(a)(1)(A)(i): self-executing dismissal before any answer
Fed. R. Civ. P. 41(a)(1)(A)(i) permits a plaintiff to terminate an action unilaterally by filing a notice of dismissal before the opposing party serves an answer or a motion for summary judgment. Because Athena Health had not served either, Security Defense Systems' notice was self-effectuating — the case closed without any court order on the merits. The dismissal was stated to be with prejudice.
Voluntarily dismissed — with prejudiceDismissal with prejudice: plaintiff cannot refile this claim against this defendant
A dismissal with prejudice is a final adjudication on the merits as between these parties. Security Defense Systems cannot bring the same infringement claims against Athena Health under US8155887B2 in a subsequent action. The patent itself remains in force and could still be asserted against other parties, but enforcement against Athena Health is foreclosed by the prejudice designation.
Bar to re-litigation vs. Athena HealthAthena Health exits without admissions or invalidity record
Athena Health avoided any merits ruling, claim construction, or invalidity finding. No answer was filed, meaning no affirmative defences or counterclaims appear in the public record. While the with-prejudice dismissal protects Athena Health from this plaintiff on these claims, it does not establish any broader precedent on the validity or scope of US8155887B2.
No merits record — clean exit for defendantUS8155887B2 remains enforceable against the broader health IT market
Because no invalidity argument was adjudicated, US8155887B2 enters the market with its presumption of validity intact. Other health IT vendors and EHR platforms offering computer visualized drug interaction features should treat this patent as an active enforcement risk. The absence of any claim construction record also means the scope of the patent's claims remains untested in litigation.
Active enforcement risk — no scope rulingFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Security Defense Systems, LLC | Company | /Search in Eureka ↗ |
| Defendant | Athena Health, Inc. | Company | /Search in Eureka ↗ |
| Plaintiff counsel | Christopher A. Honea | Attorney | Counsel for Security Defense Systems, LLCSearch in Eureka ↗ |
| Plaintiff counsel | M. Scott Fuller | Attorney | Counsel for Security Defense Systems, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Randall T. Garteiser | Attorney | Counsel for Security Defense Systems, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Rene A. Vazquez | Attorney | Counsel for Security Defense Systems, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Garteiser Honea PLLC | Law Firm | Representing Security Defense Systems, LLCSearch in Eureka ↗ |
| Defendant counsel | Rick L. Rambo | Attorney | Counsel for Athena Health, Inc.Search in Eureka ↗ |
| Defendant law firm | Morgan, Lewis & Bockius, LLP | Law Firm | Representing Athena Health, Inc.Search in Eureka ↗ |
| Presiding judge | Judge Robert Pitman | Judge | Texas Western District CourtSearch in Eureka ↗ |
R&D signals in the drug interaction and health IT IP space
Forward-looking patent and innovation intelligence around US8155887B2, Security Defense Systems' portfolio, and the competitive drug interaction information retrieval landscape.
Security Defense Systems' assertion portfolio beyond US8155887B2
Security Defense Systems has asserted US8155887B2 in at least this W.D. Texas action. Understanding the full scope of their patent holdings — including any related continuations, divisionals, or co-pending applications — helps health IT companies anticipate future assertion targets and technology domains at risk.
Patent assertion entityFiling trends in computer visualised drug interaction retrieval
The computer visualised drug interaction information retrieval space has seen continued patent activity as EHR platforms, pharmacy benefit managers, and clinical decision-support vendors expand. Mapping recent filings in this domain identifies where innovation is concentrating — and where patent thickets or white space exist for new product development.
Health IT filing trendsAthena Health's patent position in EHR and drug interaction features
Athena Health operates in the EHR and health IT platform space, where drug interaction features are table-stakes functionality. Analysing their patent filings and licensing posture in the clinical decision-support domain reveals whether they are building defensive IP to counter future assertions — and signals innovation priorities for adjacent competitors.
EHR platform IP strategyAdjacent innovation opportunities near drug interaction visualisation IP
The claim scope of US8155887B2 focuses on retrieval and visualisation of drug interaction data. Adjacent white space may exist in areas such as AI-assisted interaction prediction, patient-facing drug interaction interfaces, or interoperability-layer implementations — areas where new filings could establish freedom to operate while the core patent remains potentially asserted.
Innovation white spaceSimilar patent infringement cases: drug interaction and health IT IP in W.D. Texas
Browse patent assertion cases in the health IT and clinical decision-support space litigated in the Western District of Texas, including EHR and drug interaction technology disputes.
What this case signals for the health IT patent landscape
A pre-answer exit with prejudice in W.D. Texas leaves US8155887B2 scope untested — and the market exposed.
No merits ruling means US8155887B2 scope is entirely untested
With no claim construction, no invalidity briefing, and no answer on file, the boundaries of US8155887B2 have never been tested in court. Any health IT or EHR vendor offering drug interaction visualisation features should conduct a freedom-to-operate analysis against this patent before it surfaces in a future action against them.
W.D. Texas pre-answer dismissals often signal undisclosed negotiation
A with-prejudice dismissal filed before any responsive pleading is consistent with a negotiated resolution, though the specific terms are not disclosed in the available record. IP teams monitoring enforcement patterns should note that the plaintiff's counsel — Garteiser Honea PLLC — are active in W.D. Texas patent assertion. Tracking their docket activity provides early warning of related campaigns.
Security v Athena — key questions answered
Security Defense Systems, LLC filed a patent infringement action against Athena Health, Inc. in the Western District of Texas on April 26, 2023, asserting US8155887B2. On August 2, 2023, the plaintiff voluntarily dismissed all claims with prejudice under Fed. R. Civ. P. 41(a)(1)(A)(i), before the defendant filed any answer or summary judgment motion. The case was closed after 99 days with no merits ruling.
A dismissal with prejudice under Rule 41(a)(1)(A)(i) is a final, self-effectuating termination filed before the opposing party serves an answer. Because it is with prejudice, Security Defense Systems is barred from bringing the same infringement claims against Athena Health under US8155887B2 in a future action. No court order was required to close the case.
Yes. The dismissal only bars Security Defense Systems from re-asserting US8155887B2 against Athena Health specifically. No invalidity finding or claim construction was issued. The patent retains its presumption of validity and remains potentially enforceable against other parties in the health IT and EHR space.
US8155887B2, filed under application number US12/191759, covers computer visualized drug interaction information retrieval technology. It sits in the clinical decision-support and health informatics domain, addressing the retrieval and visual display of drug interaction data within computer-based systems. The specific claim scope has not been construed in any published litigation record.
The case was filed in the Western District of Texas (Case No. 1:23-cv-00474) and assigned to Judge Robert Pitman. The plaintiff was represented by Garteiser Honea PLLC, and the defendant was represented by Morgan, Lewis & Bockius, LLP. The case closed on August 3, 2023, 99 days after filing.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.